Human CD20/MS4A1 HEK293T Stable Cell Line
Introduction
The Human CD20/MS4A1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human CD20 protein. This stable cell line is derived from human embryonic kidney 293T cells and has been genetically modified to stably express the CD20 protein. The CD20 protein is a B-cell specific surface antigen that is involved in immune response and is a potential therapeutic target for various diseases.
Structure of CD20 Protein
The CD20 protein is a transmembrane protein with four transmembrane domains and a large extracellular loop. It is primarily expressed on the surface of B-cells, but can also be found on other immune cells such as T-cells and natural killer cells. The extracellular loop of CD20 contains multiple glycosylation sites and is the target for many therapeutic antibodies.
Activity of CD20 Protein
The CD20 protein plays a crucial role in B-cell development and function. It is involved in B-cell activation, proliferation, and differentiation. The exact function of CD20 is not fully understood, but it is believed to play a role in calcium influx and signal transduction. The CD20 protein is also a target for therapeutic antibodies, which can induce cell death in B-cells through various mechanisms such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).
Application of Human CD20/MS4A1 HEK293T Stable Cell Line
The Human CD20/MS4A1 HEK293T Stable Cell Line has various applications in research and drug development. One of the main applications is the study of CD20 protein structure and function. The stable expression of CD20 in these cells allows for the investigation of its role in B-cell biology and immune response. Additionally, this cell line can be used to screen for potential therapeutic antibodies or other drugs targeting CD20.
Flow Cytometry Analysis
Flow cytometry is a powerful technique that is commonly used to analyze the expression of cell surface markers. The Human CD20/MS4A1 HEK293T Stable Cell Line can be used in flow cytometry experiments to determine the level of CD20 expression on the cell surface. This can provide valuable information about the stability and functionality of the CD20 protein in these cells.
Therapeutic Target for B-cell Malignancies
The CD20 protein is a promising therapeutic target for B-cell malignancies such as non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The Human CD20/MS4A1 HEK293T Stable Cell Line can be used to test the efficacy of potential therapeutic antibodies or other drugs targeting CD20. This can aid in the development of novel treatments for these diseases.
Advantages of Human CD20/MS4A1 HEK293T Stable Cell Line
The use of stable cell lines has many advantages over transiently transfected cells. The Human CD20/MS4A1 HEK293T Stable Cell Line provides a consistent and reliable source of CD20-expressing cells, eliminating the need for repeated transfections. This allows for more accurate and reproducible results in experiments. Additionally, this cell line can be easily expanded and maintained in culture, making it a cost-effective option for long-term studies.
Conclusion
The Human CD20/MS4A1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the CD20 protein. Its stable expression of CD20 allows for the investigation of its role in B-cell biology and immune response, as well as its potential as a therapeutic target.
There are no reviews yet.